SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,024,965 | -35.1% | 3,365,624 | 0.0% | 1.52% | -27.6% |
Q2 2023 | $20,059,119 | +91.0% | 3,365,624 | +4.8% | 2.10% | +68.0% |
Q1 2023 | $10,499,764 | -21.0% | 3,210,937 | -4.6% | 1.25% | -36.0% |
Q4 2022 | $13,294,215 | -34.2% | 3,365,624 | 0.0% | 1.95% | -28.6% |
Q3 2022 | $20,194,000 | -6.7% | 3,365,624 | 0.0% | 2.73% | -3.3% |
Q2 2022 | $21,641,000 | -18.4% | 3,365,624 | +4.8% | 2.82% | -11.2% |
Q1 2022 | $26,522,000 | -46.6% | 3,210,937 | 0.0% | 3.18% | -14.4% |
Q4 2021 | $49,705,000 | -31.3% | 3,210,937 | 0.0% | 3.71% | -45.4% |
Q3 2021 | $72,310,000 | +14.5% | 3,210,937 | 0.0% | 6.80% | +24.9% |
Q2 2021 | $63,127,000 | – | 3,210,937 | – | 5.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |